The Effects of Different Intensity Training on Strength and Mobility of Elderly

May 14, 2021 updated by: Kamran Hosseinzadeh Ghasemabad, Universiti Putra Malaysia

The Effects of High-, Moderate-, and Low-intensity Training on Muscle Strength and Functional Mobility of Older Adults: A Randomized Controlled Trial

In this study, investigators tried to find a useful and safe way of training for the elderly population which can help this population to improve their fitness factors as fast as possible. investigators have tried to see if different intensity training has different effects on muscle strength and functional mobility of elderly women in different time points (4, 8, and 12 weeks). Investigators hypothesized that Higher intensity would be more effective to improve muscle strength and functional mobility at different time points. The participants were trained twice per week and each session contain 4 exercises ( leg press, leg extension, leg curl, and seated calf raises) and the data have been collected at the pre-test and 4th, 8th, and 12th weeks of intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kuala Lumpur, Malaysia
        • Fit House Bukit Rimao

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Aged 65 years old and above.
  • Orientation to place, time, and person, able to follow the simple instructions, and perform the exercises.
  • Without any health problems that would interfere with their safety or ability to complete high and low-intensity training such as the occurrence of myocardial infarction in the past six months, recent heart attack, uncontrolled hypertension (Blood Pressure >166/96 mm Hg), a broken leg in the past six months, diagnosed osteoporosis, and diagnosed stage three and four of heart failure.

Exclusion Criteria:

  • Participation in regular balance or lower body resistance training during the past three months (at least twice per week).
  • The health issues that might confound the study results, including lower-body neuropathy, stroke within the past year, Parkinson's disease, diagnosed vestibular disorders, severe vision (self-rated vision as poor or very poor even when wearing glasses or contact lenses), and lower-extremity joint replacements.
  • Taking the regular medication's impairing balance ability (Antidepressants, Neuroleptics or Benzodiazepines) or muscle strength (Corticosteroids).
  • Elderly with dementia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High Intensity Training (HIT)
They have trained at 80-90% of 1RM for 12 weeks, twice per week
Resistance training (4 different exercises, leg press, leg extension, leg curl, and seated calf raises)
Experimental: Moderate Intensity Training
They have trained at 65-75% of 1RM for 12 weeks, twice per week
Resistance training (4 different exercises, leg press, leg extension, leg curl, and seated calf raises)
Experimental: Low Intensity Training
They have trained at 50-60% of 1RM for 12 weeks, twice per week
Resistance training (4 different exercises, leg press, leg extension, leg curl, and seated calf raises)
No Intervention: Control Group
This groups subjects did not participate in any training

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in the Mean of 5 Time Sit to Stand Test at 4, 8, and 12 weeks
Time Frame: Baseline, 4th weeks, 8th weeks, 12th weeks
The timed that subject complete 5 times sit to stand recorded in second using a stop watch. The lower score is better
Baseline, 4th weeks, 8th weeks, 12th weeks
Change from Baseline in the Mean of the Timed Up and Go Test at 4, 8, and 12 weeks
Time Frame: Baseline, 4th weeks, 8th weeks, 12th weeks
The timed that subject complete the test recorded in second using a stop watch. The lower score is better
Baseline, 4th weeks, 8th weeks, 12th weeks
Change from Baseline in the Mean of the 6 Minutes Walking Test at 4, 8, and 12 weeks
Time Frame: Baseline, 4th weeks, 8th weeks, 12th weeks
The distance that subject walk in six minutes measured in centimetre. The higher score is better
Baseline, 4th weeks, 8th weeks, 12th weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2019

Primary Completion (Actual)

January 25, 2020

Study Completion (Actual)

January 25, 2020

Study Registration Dates

First Submitted

May 10, 2021

First Submitted That Met QC Criteria

May 14, 2021

First Posted (Actual)

May 19, 2021

Study Record Updates

Last Update Posted (Actual)

May 19, 2021

Last Update Submitted That Met QC Criteria

May 14, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Aging

Clinical Trials on Training

Subscribe